✣OncoGonFROM DISCOVERY TO IMPACT
HomeAssetsTriage & Prioritisation
3D Tumour IntelligenceExperimentsImagingSegmentation & QCResponse AnalysisAI Analysis (OSIEL)
Qualified AssetsIndustry & Data RoomCollaborationReports & Insights
Admin
Home3D Tumour IntelligenceBC-002
Loading study workspace…
3D Tumour Intelligence

BC-002

TreatmentSIMULATED MODE

Dose Response Validation

AssetOGC-BC-118CancerBreast CancerSubtypeHR+ / HER2+Model3D Tumour SpheroidLead ScientistDr. J. Patel
Review DiscussionAsk OSIEL About This Study
Response values

Treatment Response

High Dose · Day 7 · All replicates

Viability18%
Tumour Size Change-71%
Relative Volume0.29
Growth Rate-0.14/day
Confidence0.92
Response ClassStrong Response

Quantitative results for interface validation. No scientific calculation is performed.

Illustrative 3D Visualisation

Stylised tumour response · not imaging-derived geometry

High Dose · Day 7
Illustrative visualisation

Growth / Response Over Time

Relative spheroid volume

Treatment Comparison

Day 7 viability and response class

Control96% viabilityGrowth
Drug A62% viabilityPartial Response
Drug B18% viabilityStrong Response

Replicate Variability

High Dose · viability by replicate

Replicate R3 requires QC confirmation before final interpretation.

Analysis Context

Methods and governance

Image-derived metrics are illustrative and require scientist review.

Response labels require scientific review, not a validated classification.

Protocol: OG-PROT-3D-021 · Result version: v1.2

Study Context

Current scientific record

StageTreatment
QCPending
ProtocolOG-PROT-3D-025
Images64
Last Updated2026-10-02

Current Attention

Research review queue

Treatment review pendingPending QC status requires confirmation
Research data · human review required.